Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)

Treatment options for chronic myeloid leukemia (CML) have changed dramatically during the last decades. Interferon-α treatment and stem cell transplantation (SCT) clearly improved survival over conventional chemotherapy and offered the possibility of complete and durable responses. With the advent o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Henkes, Martin, van der Kuip, Heiko, Aulitzky, Walter E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2008
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2503652/
https://ncbi.nlm.nih.gov/pubmed/18728706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak